Claudine Isaacs, MD, will lead a Thursday afternoon panel discussion on the future of cancer genetics in the field of risk reduction and early detection of breast cancer.

Monica Morrow, MD, will moderate a session looking at evolving practices around axillary staging in estrogen receptor-positive breast cancer and implications on adjuvant therapies.

Heather McArthur, MD, MPH, will guide a Thursday afternoon panel discussion about how immunotherapy may expand its reach and the tools physicians can use to make therapeutic selections.

Paolo Tarantino, MD, will moderate a People’s Choice educational session on future directions in antibody-drug conjugates on Wednesday afternoon.

Plan your Wednesday schedule and don’t miss notable items on the program, including the first General Session, the keynote address from a Nobel Prize winner, and the 2024 William L. McGuire Memorial Lecture.

Christina Curtis, PhD, MSc, left, and Steffi Oesterreich, PhD, will be recognized by the American Association for Cancer Research (AACR) for significant contributions to breast cancer research.